Ignite Creation Date:
2025-12-24 @ 11:29 PM
Ignite Modification Date:
2026-02-20 @ 8:09 PM
Study NCT ID:
NCT03150056
Status:
TERMINATED
Last Update Posted:
2022-08-10
First Post:
2017-05-09
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Dose Escalation and Dose Expansion Study of GSK525762 in Combination With Androgen Deprivation Therapy in Participants With Castrate-resistant Prostate Cancer
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-07-18
Start Date Type:
ACTUAL
Primary Completion Date:
2020-07-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-06-22
Completion Date Type:
ACTUAL
First Submit Date:
2017-05-09
First Submit QC Date:
None
Study First Post Date:
2017-05-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-07-29
Results First Submit QC Date:
None
Results First Post Date:
2021-08-26
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-08-09
Last Update Post Date:
2022-08-10
Last Update Post Date Type:
ACTUAL